US 10413541
Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
granted A61KA61K31/343A61K31/496
Quick answer
US patent 10413541 (Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders) held by Lixte Biotechnology, Inc. expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Lixte Biotechnology, Inc.
- Grant date
- Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/343, A61K31/496